Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
AZZ Inc. (AZZ) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AZZ Inc. (AZZ) - free report >>
Image: Bigstock
New Strong Sell Stocks for September 10th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Shinhan Financial Group Co., Ltd. (SHG - Free Report) is a provider of financial products and services. The Zacks Consensus Estimate for its current year earnings has been revised 10.5% downward over the last 30 days.
AZZ Inc. (AZZ - Free Report) is a provider of galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and highly engineered services to the power generation, transmission, distribution, refining, and industrial markets. The Zacks Consensus Estimate for its current year earnings has been revised 22.2% downward over the last 30 days.
Chiasma, Inc. is a clinical late-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 18.6% downward over the last 30 days.
Mesa Laboratories, Inc. (MLAB - Free Report) is a designer and manufacturer of quality control instruments and disposable products. The Zacks Consensus Estimate for its current year earnings has been revised 26.4% downward over the last 30 days.
Itamar Medical Ltd. is engaged in research, development and leasing of non-invasive medical devices for the cardiology market. The Zacks Consensus Estimate for its current year earnings has been revised 18.4% downward over the last 30 days.
View the entire Zacks Rank #5 List.